Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about MRSN
Recent news which mentions MRSN
< Previous
1
2
3
4
Next >
34 Stocks Moving In Monday's Mid-Day Session
April 18, 2022
Tickers
AGRI
APCX
ARQQ
CASA
Tags
Mid/Day Movers
WE
Trading Ideas
From
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
April 14, 2022
Tickers
ABBV
AMRX
BNTX
BYSI
Tags
Government
MRSN
TRVI
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 23, 2022
Tickers
ADPT
BBLG
BPTS
CELZ
Tags
Movers
ADPT
Markets
From
Benzinga
Looking Into Mersana Therapeutics's Return On Capital Employed
March 01, 2022
Tickers
MRSN
Tags
Benzinga
Market News
Earnings
From
Benzinga
Recap: Mersana Therapeutics Q4 Earnings
February 28, 2022
Tickers
MRSN
Tags
News
MRSN
Market News
From
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Tickers
AAON
ACAD
ACHC
AGM
Tags
HNGR
KOS
VRS
From
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
Tickers
LAWS
LAZ
LII
LOVE
Tags
TCMD
Options
OTEX
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 16, 2022
Tickers
AKU
ALLO
ATXI
AUID
Tags
KMPH
Markets
SLDB
From
Benzinga
78 Biggest Movers From Friday
February 14, 2022
Tickers
AFRM
AGFY
APDN
ASTR
Tags
RSVR
EQRX
Movers From Yesterday
From
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 11, 2022
Tickers
APDN
APM
ATXI
ENSC
Tags
SRTS
ATXI
XCUR
From
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 10, 2022
Tickers
ATXI
BXRX
DRMA
ENVB
Tags
PETV
DRMA
Movers
From
Benzinga
60 Biggest Movers From Yesterday
February 10, 2022
Tickers
ABST
ADGI
AEG
ANGH
Tags
ATGE
CRKN
Trading Ideas
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 09, 2022
Tickers
BCDA
BFRA
CFMS
DCPH
Tags
BFRA
PLXP
Top Gainers
From
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 09, 2022
Tickers
ABST
ADGI
AEG
APVO
Tags
AVYA
Market News
DCFC
From
Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
Tickers
AVRO
AVXL
BMY
DCPH
Tags
RGNX
AVRO
ZSAN
From
Benzinga
Janssen Inks Over $1B Pact For Mersana's ADC Technology In Three targets
February 03, 2022
Tickers
JNJ
MRSN
Tags
Briefs
Trading Ideas
News
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
DGX
LLY
Market News
From
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 03, 2022
Tickers
AMWL
BCDA
BPTS
CRBP
Tags
CWBR
Movers
BCDA
From
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
January 05, 2022
Tickers
AMRX
ANGN
ANNX
BDSX
Tags
Financing
MRSN
INSP
From
Benzinga
Mersana Therapeutics, Synaffix Expand Cancer Pact To Potential Value Exceeding $1B
November 30, 2021
Tickers
MRSN
Tags
Contracts
Movers
Health Care
From
Benzinga
Mersana Therapeutics's Return On Capital Employed Insights
November 10, 2021
Tickers
MRSN
Tags
Benzinga
Market News
Earnings
From
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Tickers
ACHV
ACIU
AEMD
AGEN
Tags
Offerings
Benzinga
FOLD
From
Benzinga
Mersana Highlights New Preclinical Data For XMT-2056 Cancer Settings
October 08, 2021
Tickers
MRSN
Tags
Preclinical Phase
Briefs
Health Care
From
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Tickers
ABIO
ADVM
AFIB
AGRX
Tags
SNY
SPPI
AFIB
From
Benzinga
72 Biggest Movers From Yesterday
September 14, 2021
Tickers
ACH
ADGI
ADXS
AEHR
Tags
SB
CADL
TUYA
From
Benzinga
45 Stocks Moving In Monday's Mid-Day Session
September 13, 2021
Tickers
ACH
ADXS
AEHR
ATER
Tags
ACH
News
BMA
From
Benzinga
60 Biggest Movers From Friday
September 13, 2021
Tickers
ABUS
ADGI
AFRM
AMRK
Tags
Information Technology
Top Gainers
IRNT
From
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 10, 2021
Tickers
ADXS
APLS
CMAX
ENDP
Tags
CMAX
APLS
Top Gainers
From
Benzinga
41 Stocks Moving In Friday's Mid-Day Session
September 10, 2021
Tickers
ABUS
AFRM
APLS
ATER
Tags
Small Cap
Penny Stocks
FAMI
From
Benzinga
Why Are Mersana Therapeutics Shares Trading Lower On Friday?
September 10, 2021
Tickers
MRSN
Tags
Benzinga
Market News
MRSN
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today